LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Vitamin D Status Determined in Older Adults

By LabMedica International staff writers
Posted on 25 Jun 2019
Image: The complete extraction-free, fully automated Liaison XL 1,25 dihydroxyvitamin D radioimmunoassay kit (Photo courtesy of DiaSorin).
Image: The complete extraction-free, fully automated Liaison XL 1,25 dihydroxyvitamin D radioimmunoassay kit (Photo courtesy of DiaSorin).
Vitamin D has a known role in bone health, with growing evidence for beneficial effects on muscle strength and other non-skeletal outcomes. Vitamin D deficiency is often associated with adverse health outcomes in older adults. The circulating 25-hydroxyvitamin D (25(OH)D) status predominately relies on UV exposure.

Several known age-related adverse health outcomes, including bone loss, fracture risk, and falls, are associated with suboptimal serum 25-hydroxyvitamin D (25(OH)D) status (the main circulating and diagnostic metabolite of vitamin D) with further evidence for non-skeletal roles in carcinogenesis, immune function, cardiovascular disease, dementia, and all-cause mortality.

Irish scientists led by those at Trinity College (Dublin, Ireland) investigated vitamin D deficiency in community-dwelling, older adults, residing at latitudes 50⁰–55⁰ north and the study included 6,004 adults, aged over 50 years. Deficiency was categorized by two criteria: Institute of Medicine (IOM) (<30 nmol/L) and Endocrine Society (ES) (<50 nmol/L). Serum 25(OH)D was assessed from a fasting blood sample and concentrations of 25(OH)D were analyzed using the Liaison 25-hydroxyvitamin D immunoassay which yields a lower detection limit of 3.0 nmol/L.

The investigators reported that overall, the prevalence of deficiency (<30 nmol/L and <50 nmol/L) was 23.7% and 55.3%, respectively. For older age categories of ≥60 years and ≥65 years, vitamin D deficiency (<30 nmol/L) and deficiency (<50 nmol/L) were similar at 22.6% and 22.5% and 54.2% and 53.9%, respectively. The highest prevalence of deficiency (by IOM) was noted in women aged 80 years and older (36.8%), with the lowest in men aged between 70–79 years (17.3%). The overall mean 25(OH)D was 48.7 ± 23.5 (range; 9–239 nmol/L). Residing in the south of England was associated with a 22.8% lower risk of deficiency.

Maria O'Sullivan, PhD, an Associate Professor in Nutrition and a senior author of the study, said, “'Our study identified factors associated with vitamin D deficiency, including being aged 80+ years, obesity and sedentary lifestyles; all of which are increasing traits in western populations. Furthermore, this is one of the few studies to highlight the importance of non-white ethnicity in vitamin D deficiency in a large study of ageing. The findings are valuable in developing targeted strategies to eliminate vitamin D deficiency (at 30nmol/L) in older populations.”

The authors concluded that the high prevalence of vitamin D deficiency identified in the cohort highlights the need to raise awareness and have adequate public health strategies for achieving optimum vitamin D concentrations to support successful ageing. Based on their findings, there is a particular need to raise awareness and target those most at risk of vitamin D deficiency. The study was published on June 1, 2019, in the journal Nutrients.

Related Links:
Trinity College

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Sample Transportation System
Tempus1800 Necto

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more